Clinical trials have been initiated globally across various therapeutic areas from 2018 to 2024. The scope and characteristics of these trials, including their geographic distribution and focus areas, are being tracked and analyzed. Details about specific trials, such as those related to kidney injury, oncology, and leukemia, as well as advancements in biopharma and disease research, are also being reported.